LHC Group - LHCG Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LHC Group in the last year. There are currently 8 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" LHCG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LHCG, but not buy additional shares or sell existing shares.
View LHCG analyst ratings or view top-rated stocks.

8 Wall Street research analysts have issued 12-month price objectives for LHC Group's stock. Their LHCG share price forecasts range from $170.00 to $185.00. On average, they expect the company's stock price to reach $172.50 in the next year. This suggests a possible upside of 2.5% from the stock's current price.
View analysts price targets for LHCG or view top-rated stocks among Wall Street analysts.

LHC Group's stock was trading at $137.23 at the start of the year. Since then, LHCG shares have increased by 22.6% and is now trading at $168.28.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our LHCG earnings forecast.

LHC Group, Inc. (NASDAQ:LHCG) issued its quarterly earnings results on Wednesday, November, 3rd. The health services provider reported $1.45 earnings per share for the quarter, hitting the consensus estimate of $1.45. The health services provider had revenue of $565.45 million for the quarter, compared to the consensus estimate of $565.30 million. LHC Group had a trailing twelve-month return on equity of 8.13% and a net margin of 2.73%. During the same period in the prior year, the business posted $1.63 EPS.

524 employees have rated LHC Group Chief Executive Officer Keith G. Myers on Glassdoor.com. Keith G. Myers has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other LHC Group investors own include Verizon Communications (VZ), NVIDIA (NVDA), Home Depot (HD), Cisco Systems (CSCO), Visa (V), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA), Chevron (CVX) and Intel (INTC).

LHC Group trades on the NASDAQ under the ticker symbol "LHCG."

LHC Group's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (14.34%), Vanguard Group Inc. (9.26%), Alpine Associates Management Inc. (3.21%), State Street Corp (3.16%), Westchester Capital Management LLC (2.00%) and Dimensional Fund Advisors LP (1.71%). Insiders that own company stock include Nicholas Gachassin III, Ronald T Nixon and W Earl Reed III.
View institutional ownership trends.

Shares of LHCG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LHCG stock can currently be purchased for approximately $168.28.

LHC Group (NASDAQ:LHCG) has a market capitalization of $5.22 billion and generates $2.22 billion in revenue each year. The health services provider earns $115.73 million in net income (profit) each year or $2.05 on an earnings per share basis.

The company employs 30,000 workers across the globe.

LHC Group's mailing address is 901 HUGH WALLIS ROAD SOUTH, LAFAYETTE LA, 70508. The official website for the company is www.lhcgroup.com. The health services provider can be reached via phone at (337) 233-1307, via email at eric.elliott@lhcgroup.com, or via fax at 337-235-8037.